The objective of the present study was to analyze the impact of metabolic syndrome (MS) and its individual components on oxidative stress (OX) and on the activity of antioxidant enzymes of patients with essential hypertension. One hundred and eighty-seven hypertensives, 127 (61.9%) of them having criteria for MS according to the International Diabetes Federation criteria and 30 healthy normotensive subjects were included. OX status was assessed by measuring glutathione oxidized/glutathione reduced and reactive oxygen species-induced byproducts of lipid peroxidation, malondialdehide, and DNA damage, 8-oxo-dG genomic and mitochondrial. Antioxidant enzymatic activity of Cu/Zn extracellular-superoxide dismutase (SOD) and catalase (CAT) was measured in plasma and glutathione peroxidase 1 in hemolysad erythrocytes. In mononuclear cells, total-SOD activity, CAT and glutathione peroxidase 1, were assessed as well. The OX state in both blood and peripheral mononuclear cells observed in hypertensives were not enhanced by the addition of components of the so-called MS. Likewise, the reduction in the activity of antioxidant enzymes, both extracellular and cytoplasmic, was not affected by the presence of additional components of the MS. Neither the number of components nor the individual addition of each of them, low high-density lipoprotein, triglycerides, abdominal obesity or fasting glucose, further impact in the OX abnormalities observed in those with only hypertension in absence of other components. In conclusion, the present data indicates that contribution of MS components to the OX burden generated by high blood pressure is minimal.
Introduction
Metabolic syndrome (MS) is currently considered to be a cluster of metabolic and cardiovascular (CV) risk factors which together increase CV and renal risk. Although MS has been defined several ways by different organizations, and these definitions have been challenged, high blood pressure (BP) values, abdominal obesity, dyslipidemia and subtle increase in baseline glucose are diagnostic criteria shared by all.
High BP values are one of the main MS components, and MS has been found in about 30-40% of hypertensives. Whether or not the presence of MS increases the hypertension-induced CV risk is a matter of debate. Moreover, recently criticisms about the existence of MS have been raised, and there are doubts concerning whether MS itself confers more risk than the sum effect of each of the components. 1 Excessive production of reactive oxygen species (ROS), which outstrip antioxidant defence mechanisms, has been implicated in pathophysiological conditions that impact on the CV system. Hypertension is considered a state of oxidative stress (OX) that can contribute to the development of artherosclerosis 2 and other hypertension-induced organ damage. 3 Assessment of antioxidant activities and lipid peroxidation byproducts in hypertensives indicates an excessive amount of ROS and a reduction of antioxidant mechanism activity in blood, as well as in several other cellular systems, 4 including not only vascular wall cells, 5 but also those cells found in circulating blood. 6, 7 Increased OX of hypertensive subjects improved with the antihypertensive treatment, and extending treatment over time increased the beneficial impact of treatment.
The clinical relevance of OX and of antioxidant mechanisms has most recently received support in a paper that linked the activity of glutathione peroxidase type 1 (GPx1), one of the most important cytoplasmic antioxidant enzymatic systems, to the risk of CV events in a population with coronary heart disease. 9 The lower the activity, the higher the risk. Therefore, assessment of OX and/or antioxidant activities may indicate the level of risk.
The objective of the present study was to analyze the impact of MS and its components on OX and on the activity of antioxidant enzymes of patients with essential hypertension. OX status was assessed by measuring oxidized glutathione/reduced glutathione (GSSG/GSH) and ROS-induced byproducts of lipid peroxidation, malondialdehide (MDA), and DNA damage, 8-oxo-dG genomic and mitochondrial. Antioxidant enzymatic activity of Cu/Zn extracellular-superoxide dismutase (Cu/Zn-Ec-SOD), catalase (CAT) and GPx1 was measured in plasma. In mononuclear cells, total-SOD activity, CAT and GPx1 were assessed as well.
Patients and methods

Selection of study participants
Patients included in the study were selected from an outpatient clinic over the 3-year period of January 2001 to December 2003. Patients who fulfilled the inclusion criteria were invited to participate, and written consent was requested. The following were the inclusion criteria: (a) essential hypertension defined according to the criteria of the VI Joint National Committee; 10 (b) aged 25-50 years; (c) WHO grade I-II; (d) never previously treated for hypertension or with uncompliant treatment and off medication for at least 1 month before the beginning of the study. Patients with diabetes mellitus or smoking 410 cigarettes/day were excluded. A group of healthy, normotensive non-smokers were selected as a control group. The Ethics Committee of the Hospital approved the study.
Measurements of the components of MS MS was defined following the International Diabetes Federation (IDF) criteria.
11 BP was measured using a mercury sphygmomanometer with the patient in the sitting position after 5 min of rest in a quiet environment, following the recommendations of the British Hypertension Society. Systolic BP (SBP), diastolic BP (DBP) (Korotkoff phase I and phase V, respectively) and mean BP (MBP) were averaged using three readings measured at 5 min intervals. Waist circumference was measured in a standing position using standardized criteria. 12 Blood samples for glucose values and lipid profile were obtained in the morning after a minimum of 8 h fasting. Serum biochemical profiles were measured using an autoanalyzer.
In addition, ambulatory BP monitoring was performed using an oscillometric monitor (Spacelabs 90202 or 90207) on a regular work day. Following the standard protocol, recording began between 0830 and 0900 with readings taken every 20 min from 0600 until midnight and every 30 min from midnight to 600. Before starting the study, the reliability of the BPs values measured with the monitor were checked against simultaneous measurements by a mercury sphygmomanometer. Differences of less than 5 mm Hg were allowed. Irregularities in BP readings were rejected automatically when SBP was 4270 or o70 mm Hg, or DBP was 4160 or o40 mm Hg. Those patients with recordings showing an error rate of 425% of the total readings were excluded from the study.
Blood samples and analytical procedures
One milliliter of whole blood was centrifuged at 13000 r.p.m. during 30 min. An aliquot of the supernatant was collected and used for GSH determination, previous addition of 10 ml 20% perchloric acid solution, a second one was used to assess CAT and Cu/Zn-Ec-SOD measurement and a third one transferred to a new tube and stored at À801C to await MDA determination. An equivalent volume of distilled water was added to the cell pellet and vortex until complete mixing was achieved. The hemolized sample was stored at 41C during 2 h and aliquots of 200 ml were used for GPx and hemoglobin analysis.
Heparinized whole blood was diluted with saline medium and mononuclear cells were isolated by Ficoll-Hypaque centrifugation followed by three washes. GSH content of cells was determined using a previously described assay. 13 For the analysis of GSSG, samples were treated with N-ethylmaleimide and bathophenanthroline disulfonic acid, derivatized and analyzed by high-performance liquid columns (HPLC) as described previously.
14 MDA was analyzed by HPLC. 15 The protein content was measured by the Bradford method.
Total SOD activity was measured according to the McCord and Fridowich method 16 based on the production of superoxide radicals during the conversion of xanthine to uric acid by xanthine oxidase and the inhibition of cytochrome c reduction. One unit of SOD activity was defined as the amount of SOD that produces 50% inhibition of cytochrome c reduction. CAT and GPx activities were determined following the Clairbone 16 and the Gunzler and Flohe methods referred by McCord and Fridowich. 17 Genomic and mitochondrial DNA extraction Cell DNA was isolated following the Gupta method with the modification described by Muñ iz 18 in which chloroform isoamyl alcohol (24:1) is used instead of phenol for the removal of proteins. Isolated DNA was washed twice with 70% ethanol, dried and dissolved in 200 ml of 10 mM Tris/HCl, 0.1 mM ethylenediaminetetraacetic acid, 100 mM NaCl, (pH 7.0) for its enzymatic digestion, as described previously. 17 In brief, 5 mg DNA/ml (total DNA 200 mg) was incubated with 100 U of DNase I in 40 ml Tris/HCl (10 mM) and 10 ml of 0.5 M MgCl 2 (the final concentration of 20 mM) at 371C for 1 h. The pH of the reaction mixture was then lowered with 15 ml of sodium acetate 0.5 M to pH 5.1. Next, 10 ml of nuclease P1 (5 U) and 30 ml of 10 mM ZnSO 4 were added to give a final concentration of 1 mM, and the mixture was incubated for 1 h. After readjusting the pH with 100 ml of 0.4 M Tris/HCl (pH 7.8) followed by the addition of 20 ml alkaline phosphate (3 U), the samples were incubated for 30 min. Enzymes were precipitated with acetone (5 vol), removed by centrifugation, and the supernatant evaporated to dryness.
8-oxo-deoxyguanosine assay DNA hydrolysates were dissolved in HPLC grade water and filtered through a 0.2-mm. syringe filter before applying the samples to a Waters ODS HPLC column (2.5 Â 0.46 i.d.; 5 m particle size). The amount of 8-oxo-deoxyguanosine (8-oxo-dG) and deoxyguanosine (dG) in the DNA digest was measured by electrochemical and UV absorbance detection, under the elution conditions previously described. 18 Standard samples of dG and 8-oxo-dG were analyzed to assure their good separation and to allow for identification of those derived from cell DNA.
Statistical analysis
For each variable, the values were expressed as mean7s.d. or s.e. values. The calculation for the intra-assay reproducibility for the OX parameters used the Bland and Altman method 19 in a subgroup of 12 subjects. The coefficients of repeatability, expressed as a percentage of the nearly maximal variation, namely four s.d. of the measurement under investigation, were the following: GSH 2%; activity of SOD, CAT and GPx ranged from 2 to 8%; and for MDA 15%, genomic DNA 23% and mitochondrial DNA 11%. The lower the value, the higher the reproducibility.
The differences between groups were sought using analysis of variance one-way for continuous variables, with Bonferroni correction for multiple comparisons, and w 2 for discontinuous variables. Pearson's correlation coefficients were calculated among each of the components of MS and the OX measurements. A multiple regression analysis was performed using OX parameters (GSSG/GSH or MDA in plasma; GSSG/GSH, MDA, genomic or mitochondrial 8-oxo-dG in peripheral mononuclear cells) as dependent variables, and the components of MS as independent variables. Two-tailed values of Po0.05 were considered statistically significant.
Results
General characteristics and BP values of the study population
The study was performed in 187 hypertensives, 127 (61. 9%) of them having criteria for MS according to the IDF criteria. Thirty normotensive subjects in absence of MS were also included. The characteristics of the patients grouped by the number of components of MS and the controls are shown in Table 1 . Controls were normotensive and had lower body mass index (BMI), abdominal circumference and slightly higher high-density lipoprotein (HDL)-cholesterol levels as compared to hypertensives. Among the hypertensives and according to the number of components of the MS, significant differences between groups were observed in terms of age, sex distribution, BMI, waist circumference, fasting glucose, triglycerides and HDL-cholesterol (Table 2 ). In addition, ambulatory MBP tended to be higher throughout the spectrum of MS components; the higher the number of components the higher the BP values.
OX in hypertensives and controls
Blood of hypertensive subjects showed significantly lower GSSG/GSH values and significantly higher MDA values than those observed in the control group (Table 3) . Likewise, a significant difference exists between hypertensives and controls in terms of GSSG/GSH, 8-oxo-dG genomic and mitochondrial values measured in mononuclear cells. The above indicated that hypertensives have an increase in OX. Besides the increment in the oxidative status, there was a significantly lower activity level for the antioxidant enzymes Cu/Zn-extracellular SOD, CAT in plasma and GPx1 in hemolyzed erythrocytes when compared to that observed in the normotensive subjects (Table 3) . Likewise, the activity of total SOD, CAT and GPx1 in mononuclear cells was also reduced in hypertensives as compared to controls. Hypertensives were stratified by the number of components of MS. All subjects had at least one component as all of them were hypertensives. As is shown in Table 5 , none of the assessed parameters in blood, levels of GSH, GSSG, MDA, nor the activity of antioxidant enzymes differed among the hypertensives grouped by the number of components of the MS. Likewise, in mononuclear peripheral cells, no differences in antioxidant enzymatic activity or oxidative-derived by-products were observed within the groups of hypertensives. 
Abbreviations: GPx, glutathione peroxidase; GSSG/GSH, oxidized glutathione/reduced glutathione; Hb, hemoglobin; HDL, high-density lipoprotein; MDA, malondialdehide; SOD, superoxide dismutase. Values are average (95% CI); (number of patients).
Oxidative stress in hypertensives and metabolic syndrome N Abdilla et al 0.72, 0.31; respectively) and with or without high waist circumference (P-values 0.92; 0.47; 0.35; 0.65; respectively) defined according to the IDF criteria.
Discussion
The OX state assessed by the increased GSSG/GSH and the increment of ROS-derived by-product in both blood and peripheral mononuclear cells observed in hypertensives were not enhanced by the addition of components of the so-called MS. Likewise, the reduction in the activity of antioxidant enzymes, both extracellular and cytoplasmic, was not affected by the presence of additional components of the MS. Neither the number of components nor the individual addition of each of them, low HDL, triglycerides, abdominal obesity or fasting glucose, further impact in the OX abnormalities observed in those with only hypertension in absence of other components. The characteristics of the study population and the methods used to assess OX and antioxidant mechanisms avoid potential bias. Hypertensives were recruited from a referral Hypertension Clinic, but none of them have received antihypertensive treatment regularly. Indeed, 85% of the subjects had never been treated with antihypertensive drugs. Moreover, and in all the patients, clinical assessment, analytical procedure and the OX parameters were assessed at least 1 month after the end of medication. Inclusion criteria also restrict the possibility that the observed changes were strongly influenced by high levels of cholesterol or by smoking. Despite all of these characteristics, the limitations of the study come from the number of subjects analyzed. Absence of previous studies did not allow us to calculate the power of the study and the sample size necessary. Similar levels of the OX parameters in subjects with 1, 2, 3 or 4 MS components, however, make it difficult to find differences even if we increase the sample size.
To assess OX, a large battery of tests including not only the oxidized over the GSH but also measurement of ROS-derived products from lipid peroxidation, 20 proteins, 21 and from the repair of genomic and mitochondrial DNA was used. A large number of parameters for assessment of OX have been used, and no recommendation about what is the best is available now. Measurement of several parameters, which explore different expressions of OX avoids the possibility of having OX activation undetected by the methods used. Antioxidant enzyme activities in blood and in the cytoplasm were also analyzed giving complementary information of the state of OX in the study population, as lower activity of the antioxidant enzymes have been reported in chronic OX states. A word of caution, however, needs to be introduced at the time of evaluating OX parameters and activity of antioxidant mechanisms measured in blood and mononuclear peripheral cells. The data only reflect what is happening in plasma and circulating mononuclear cells, so even though receiving the imprinting of hemodynamic and circulating hormones and cytokines, it is not necessarily what occurs in the vascular wall.
The significance of the present data deserves some comments, although the real meaning can only be delineated with prospective studies, which analyze the relationship between OX values and CV outcomes in hypertensive subjects. The prognostic value of OX or of the antioxidant mechanisms has been analyzed in subjects with coronary heart disease but the prognostic value in a population with a lower CV risk profile has not been assessed.
The first comment is about the high level of OX and the low activity of antioxidant enzymes in subjects with essential hypertension. OX accompanying hypertension in animal models includes spontaneous hypertension, 22 renovascular hypertension, 23 deoxycorticosterone acetate-salt hypertension model 24 and obesity-related hypertension. 25 Moreover, reducing superoxide radicals by infusion of SOD significantly decreases BP in spontaneously hypertensive rats. 26 In humans, hypertension is also considered a state of OX that can be related to the development of artherosclerosis 27 and other hypertension-induced organ damage, 28 microalbuminuria. The increased OX in hypertensives has been attributed to the overactivity of mechanisms that increase ROS production which is mainly mediated by superoxide and hydroxyl radicals. 4, 5 An alternative explanation for the high OX status observed in hypertensives, which does not exclude the former, is the impact of primary impairment of antioxidant enzymatic activity. Antioxidant enzymes constitute and represent an important part of the total antioxidant activity of aerobic cells and coordination of their functions results in the maintenance of ROS below critical levels compatible with cell viability and performance. Every one of the antioxidant enzymes is susceptible to ROS inactivation and their oxidation leads to the degradation of enzymes by proteosome at a high ratio. [29] [30] [31] The next comment is on the absence of a further increment in OX after the addition of one, two, three or four components of the MS to the basic one, hypertension, was analyzed. Likewise, the addition of the individual components, low HDL, high triglycerides, abdominal obesity or impaired fasting glucose, separately, did not increase the OX level. The importance of OX in MS, playing a key role in the development of insulin resistance and impaired insulin secretion, has been suggested. Increased ROS promotes free fatty acid liberation and deregulation of adipocytokines in adipose tissue, and furthermore decreases glucose uptake in the skeletal muscle and liver. The absence of differences between hypertensives, with or without MS in the OX parameters measured in the present study may be explained. Once the mechanisms of OX in mononuclear cells and in the blood are activated in the presence of hypertension, an additional factor, which potentially stimulates OX generation cannot further increase OX. Whether or not another potent triggers of OX linked to MS, such as diabetes, can increase the OX in hypertensive subjects has not been explored in the present study in which diabetes was an exclusion criteria.
The last comment is related to the implications of the observed changes in the generation of vascular and organ damage. Vascular damage results from a complex interaction of mechanisms, which lead, among other things, to endothelial dysfunction, migration and modification of smooth muscle cells, lipid overload and inflammation. Although an increase in OX plays a key role in the development and progression of these alterations, this is not the unique mechanism acting in the complex process, which leads to vascular damage. Reactive oxygen products from the peripheral mononuclear cells and those expressed in blood may contribute to the endothelial dysfunction and to the organ damage present in hypertensive subjects, although the proportion of the total OX burden in the vascular wall is not well known. Given the present data, the contribution of circulating OX in subjects with hypertension is not further increased when other components of the MS are present. This does not exclude the potential impact on the ROS production in the cellular component of the vascular wall or the impact on other mechanisms of lesion.
In summary, enhanced OX and a decrease in antioxidant enzymatic mechanisms are present in the mononuclear cells and blood of hypertensive subjects, both in the presence of and in the absence of MS. Neither the sum of the components of MS, nor each of them individually, increased the degree of the alterations observed. This indicates that their contribution to the OX burden generated by high BP is minimal. Whether the persistence of MS components after BP reduction by antihypertensive treatment blunts the improvement of OX needs to be assessed in prospective studies.
